Keywords: baxter, reports, positive, data, ph, i/ii, h5n1

Baxter reports positive data from Ph I/II H5N1 vacc trial

Article | 09 April 2007

Print This

Illinois, USA-based drugmaker Baxter International says that final data from a Phase I/II trial of its adjuvant-free, developmental pandemic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in